Literature DB >> 9733855

Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8.

S Kliche1, E Kremmer, W Hammerschmidt, U Koszinowski, J Haas.   

Abstract

In patients with Kaposi's sarcoma (KS), human herpesvirus 8 (HHV-8) can invariably be detected in KS tumor tissue and, at a lower frequency, in prostate tissue and peripheral blood B lymphocytes. Whereas the majority of KS spindle cells are latently infected by HHV-8, linear HHV-8 genomes characteristic for lytic infection are found predominantly in the peripheral blood cells of KS patients. In this study, we show that HHV-8 can stably infect B lymphocytes in vitro in the presence of Epstein-Barr virus (EBV). We were able to generate immortalized HHV-8(+)/EBV+ lymphoblastoid cell lines (LCLs) derived from peripheral blood mononuclear cells (PBMC) of EBV- and EBV+ donors. In HHV-8(+)/EBV+ LCLs, which have the phenotype of activated B lymphocytes (CD19(+), surface immunoglobulin M, CD23(+), CD30(+), CD80(+)), HHV-8 was still present after more than 25 passages (more than 9 months of culture). Latent viral transcripts and proteins were present in nonstimulated HHV-8(+)/EBV+ LCLs. After induction by phorbol ester and n-butyrate, HHV-8(+)/EBV+ LCLs expressed lytic HHV-8 transcripts and proteins. Moreover, HHV-8 could be serially passaged from HHV-8(+)/EBV+ LCLs to fresh PBMC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733855      PMCID: PMC110154     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

Authors:  P S Moore; C Boshoff; R A Weiss; Y Chang
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

2.  Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  R Renne; D Blackbourn; D Whitby; J Levy; D Ganem
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.

Authors:  E Cesarman; R G Nador; F Bai; R A Bohenzky; J J Russo; P S Moore; Y Chang; D M Knowles
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

6.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.

Authors:  D H Kedes; E Operskalski; M Busch; R Kohn; J Flood; D Ganem
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

Authors:  A G Eliopoulos; C W Dawson; G Mosialos; J E Floettmann; M Rowe; R J Armitage; J Dawson; J M Zapata; D J Kerr; M J Wakelam; J C Reed; E Kieff; L S Young
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

9.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

10.  The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

Authors:  L L Decker; P Shankar; G Khan; R B Freeman; B J Dezube; J Lieberman; D A Thorley-Lawson
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  20 in total

1.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Oncogenic herpesviruses sending mixed signals.

Authors:  D Michiel Pegtel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-19       Impact factor: 11.205

5.  Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.

Authors:  Lei Chen; Michael Lagunoff
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

7.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.

Authors:  Rachele Bigi; Justin T Landis; Hyowon An; Carolina Caro-Vegas; Nancy Raab-Traub; Dirk P Dittmer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-14       Impact factor: 11.205

9.  Use of a BJAB-derived cell line for isolation of human herpesvirus 8.

Authors:  Paola Gasperini; Massimo Barbierato; Canio Martinelli; Paolo Rigotti; Francesco Marchini; Giulia Masserizzi; Francesco Leoncini; Luigi Chieco-Bianchi; Thomas F Schulz; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

10.  Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.

Authors:  Joseph H Jeong; Rebecca Hines-Boykin; John D Ash; Dirk P Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.